Growth in the live cell imaging market can primarily be attributed to various factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research.

The Live Cell Imaging market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9%.

+ Market Dynamics 

+ Drivers

+ Rising Adoption of High-Content Screening Techniques in Drug Discovery
+ Rising Incidence of Cancer
+ Growing Availability of Funds for Research

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163914483

The global live cell imaging market is segmented into instruments, consumables, software, and services. In 2018, the instruments segment accounted for the largest share of the live cell imaging market. Factors such as the launch of new and advanced instruments, increasing incidence of diseases, and rising government initiatives and awareness programs for promoting cell-based research are the major factors driving the demand for live cell imaging instruments.

The live cell imaging market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). The academic & research institutes segment is expected to grow at a higher CAGR during the forecast period.

View complete press release:-
https://www.marketsandmarkets.com/PressReleases/live-cell-imaging.asp